A Bold Call on Biotech ETFs
March 26, 2015 at 14:01 PM EDT
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotechnology exchange traded fund, is off 8.4% over the past week. While that is not the official definition of a correction, a 10% decline is needed for a security to enter correction territory, acute weakness in IBB and rival...